SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

22nd Century Group (XXII)

XXII RSS Feed
Add XXII Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, Tamtam, kei, gilbe, esad1, 2014shelby
Search This Board: 
Last Post: 8/19/2017 2:30:57 PM - Followers: 368 - Board type: Free - Posts Today: 12

 

http://images.investorshub.advfn.com/images/converted/635585528992044209.png


http://www.xxiicentury.com/xxii2015/wp-content/uploads/2011/04/brand-A-web-217x300.jpghttp://www.xxiicentury.com/xxii2015/wp-content/uploads/2011/05/brand-B-web-217x300.jpghttp://www.xxiicentury.com/xxii2015/wp-content/uploads/2011/05/Spectrum-web21.jpghttp://www.xxiicentury.com/xxii2015/wp-content/uploads/2015/03/Moonlight-packs.jpg



Ticker: XXII (NYSE MKT)
Latest Share Structure:
O/S - 76,009,960 (from 10-k)

Website       SEC Results      Recent News      Major Holders      Analyst Reports     Company Info/Contact

                                                                           22nd Century Group:                                                  Red Sun Cigarettes:      
                                                                                                                                                                                                                    
                                                                                                         
22nd Century is a plant biotechnology company with an important mission: To Reduce the Harm Caused by Smoking.

Our long-term focus is the research, development, licensing, manufacturing, and worldwide sales and distribution of our important products. 22nd Century Group’s proprietary genetic engineering technology and plant breeding expertise allow us to regulate the level of nicotine (and other nicotinic alkaloids) in the tobacco plant. As a result of our unique technology, we are able to grow tobacco with up to 97% less nicotine than conventional tobacco – as well as plants with relatively high nicotine levels. The applications for this technology are extraordinary; in independent clinical studies, our very low nicotine (VLN) tobacco has demonstrated remarkable efficacy as a smoking cessation aid. On the other hand, for smokers who do not wish to quit, our high nicotine tobacco enables us to produce a cigarette with what we believe is the world’s lowest tar-to-nicotine ratio.

We believe that the tobacco industry is at the beginning of a paradigm shift toward the development and commercialization of reduced-risk tobacco products which represent a significant step toward achieving the public health objective of harm reduction. Our 18 years of research and development on the tobacco plant, mainly on the nicotine biosynthetic pathway, uniquely positions us to become a major benefactor of this paradigm shift developing in the tobacco industry. Our technology has created, and will continue to develop, a pipeline of products.

We are primarily involved in the following activities:

The international licensing of 22nd Century Ltd’s technology, proprietary tobaccos, and trademarks;
The research and development of potentially reduced-risk or modified risk tobacco products;
The development of X-22, a prescription-based smoking cessation aid consisting of very low nicotine cigarettes;
The manufacture, marketing and international distribution of RED SUN and MAGIC proprietary cigarettes;
The production of SPECTRUM research cigarettes for the National Institute of Drug Abuse (NIDA); and
The contract manufacturing of other companies’ branded tobacco products.

Protecting our technology are 200 issued patents in 96 countries plus over 50 additional pending patent applications. Goodrich Tobacco Company, LLC, Botanical Genetics, Nasco Products, LLC, and Hercules Pharmaceuticals, LLC are wholly-owned subsidiaries of 22nd Century Group.

Quick Research Links:

 Microcap Research Reports
Bionap, Inc.


XXII Current Stock Chart:

 

                   All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp


 

XXII
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
XXII News: Statement of Changes in Beneficial Ownership (4) 08/17/2017 04:13:20 PM
XXII News: Statement of Changes in Beneficial Ownership (4) 08/17/2017 04:11:31 PM
XXII News: FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators 08/16/2017 08:45:00 AM
XXII News: 22nd Century Group Files 2017 Second Quarter Report and Announces Conference Call to Provide Business Update 08/09/2017 04:15:00 PM
XXII News: Quarterly Report (10-q) 08/09/2017 04:09:29 PM
PostSubject
#36126  Sticky Note wow: FDA's Plan to Lower Nicotine in Cigarettes to Atlanta1 07/31/17 07:29:06 AM
#31769  Sticky Note Summary Below: Court rejected Crede’s motion for preliminary injunctive Zedster 06/29/16 11:12:33 AM
#36805   Recalling from memory 3 years ago. Trying to Justfactsmam 08/19/17 02:30:56 PM
#36804   ,...read what was posted...they appear to get add-ons Justfactsmam 08/19/17 02:24:43 PM
#36803   On the conference call Henry said: vl39 08/19/17 01:43:19 PM
#36802   This is what Henry said on conference call: vl39 08/19/17 12:28:48 PM
#36801   Based upon the posted info the BAT deal 2014shelby 08/19/17 10:47:11 AM
#36800   I agree - the time frame is irrelevant, brooklyn13 08/19/17 10:03:09 AM
#36799   Dr. Gottlieb is scientifically on target reducing nicotine biotech2 08/19/17 09:29:53 AM
#36798   Lol. But wait. Didn't you say tobacco companies Lnp30 08/19/17 08:57:59 AM
#36797   ...not 50%...25%! Justfactsmam 08/19/17 08:32:01 AM
#36796   WRONG!...ask the company to be a little more Justfactsmam 08/19/17 08:23:51 AM
#36795   Seriously, connect the dots... nonameface13 08/19/17 12:07:57 AM
#36794   Hope everyone here is doing well! Been The Lost Trader 08/19/17 12:02:00 AM
#36793   Send that to all the women in America. PICHNPENYS2THPNTHOUS 08/18/17 11:01:32 PM
#36792   Be smart enough to connect the dots... nonameface13 08/18/17 10:09:40 PM
#36791   Yes. Strong. Kind of enjoy XXII acting like PICHNPENYS2THPNTHOUS 08/18/17 07:53:24 PM
#36790   Nice buying into today close The Rainmaker 08/18/17 04:11:26 PM
#36789   Absolutely...I think Henry is hoping they walk away esad1 08/18/17 04:07:35 PM
#36788   1% market share = $4b, use any discount biotech2 08/18/17 02:22:47 PM
#36787   XXII gets 50 % of royalties under BAT biotech2 08/18/17 02:12:21 PM
#36786   Most smokers want to quit for their health. Zedster 08/18/17 01:30:25 PM
#36785   ...a lot more complicated then it appears. Justfactsmam 08/18/17 11:34:21 AM
#36784   That would probably hurt PM stock eh? That's Lnp30 08/18/17 11:05:29 AM
#36783   It was a lousy deal financially done by esad1 08/18/17 10:54:12 AM
#36782   ...a more curious question is why those commenting Justfactsmam 08/18/17 09:36:33 AM
#36781   I respect your interpretation of the BAT deal Lnp30 08/18/17 09:18:21 AM
#36780   ...yes anyone can buy them "subject to" BAT's Justfactsmam 08/18/17 09:03:41 AM
#36778   XXII can be bought out by anyone. The Lnp30 08/18/17 07:19:14 AM
#36777   XXII This vehicle is a clear case of trade DeliverySuccess 08/18/17 06:42:52 AM
#36776   What about all the other XXII patents and 2014shelby 08/18/17 04:41:45 AM
#36775   On Oct 1st, 2013 (announcement date) British American Justfactsmam 08/18/17 04:08:14 AM
#36774   Gilbe... "Will it take time to implement? Yes, absolutely...likely Justfactsmam 08/18/17 03:28:46 AM
#36773   Watching the 200 MA on the 30 minute chart Sendme 08/18/17 12:39:32 AM
#36772   Not sure what you mean Lnp30 08/17/17 11:12:11 PM
#36771   And how about BAT? Good/bad/ indifferent deal for 2014shelby 08/17/17 10:57:30 PM
#36770   The focus here to me is X22 or Lnp30 08/17/17 10:50:27 PM
#36769   You may be over thinking this a bit :) gilbe 08/17/17 05:50:49 PM
#36768   Your words, not mine...where are you getting Gottlieb Justfactsmam 08/17/17 04:31:51 PM
#36766   It was a no brainer after continued FDA Zedster 08/17/17 10:24:26 AM
#36765   Someone just made some large buys 300k Reeves 08/17/17 10:16:01 AM
#36764   Interesting how so far the top blue trend Sendme 08/17/17 09:54:25 AM
#36762   I cant find the part calling for more The Rainmaker 08/16/17 11:09:48 PM
#36761   NO WHERE does Gottlieb say MORE studies need nonameface13 08/16/17 10:17:44 PM
#36760   http://www.prnewswire.com/news-releases/fda-proposal-puts-spotlight-on-big-tobac esad1 08/16/17 09:59:11 PM
#36759   ...the article by Gottlieb clearly expresses that more Justfactsmam 08/16/17 09:14:06 PM
#36758   One good rule of thumb is that when Sendme 08/16/17 08:57:42 PM
#36757   This article in the New England Journal of vl39 08/16/17 08:47:58 PM
#36756   Not sure why this article focus so much Frenchy2016 08/16/17 07:08:17 PM
#36755   Comprehensive Nicotine Regulation to End the Combustible Tobacco Zedster 08/16/17 06:47:52 PM
#36754   Just Published In New England Journal of Medicine nejm.org/action/cookieAbsent vl39 08/16/17 06:43:55 PM
#36752   FDA Proposal Puts Spotlight on Big Tobacco and sxdcfv 08/16/17 03:44:17 PM
PostSubject